NCT03360448View on ClinicalTrials.gov

AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2023

Conditions
Heart Failure
Interventions
DRUG

Ad5.hAC6

1:1 randomization (Ad5.hAC6 : placebo) - intracoronary delivery

DRUG

Placebo

1:1 randomization (Ad5.hAC6 : placebo) - intracoronary delivery

Sponsors
All Listed Sponsors
lead

Renova Therapeutics

INDUSTRY